Deal is part of mission to increase options available prescribers, patients and the NHS More: ALTURiX Acquires UK rights to desmopressin oral solution Source: News
read moreMore former Bristol Myers employees sue over COVID-19 vaccination brouhaha kdunleavy Wed, 10/05/2022 – 06:48 More: More former Bristol Myers employees sue over COVID-19 vaccination brouhaha Source: fierce
read moreOn 20-21 September 2022, the FlyPharma Conference Europe made a welcome return as a live, in-person event More: FlyPharma Conference Europe 2022 shares the latest supply chain challenges and advice for better industry collaboration Source: News
read moreAfter years of manufacturing woes, Takeda is calling it quits on Natpara fkansteiner Tue, 10/04/2022 – 14:36 More: After years of manufacturing woes, Takeda is calling it quits on Natpara Source: fierce
read moreIn Daiichi case, court upholds jury’s $177.8M infringement ruling against Novartis zbecker Tue, 10/04/2022 – 11:18 More: In Daiichi case, court upholds jury's 7.8M infringement ruling against Novartis Source: fierce
read moreAstraZeneca’s Evusheld loses potency against new omicron subvariant, FDA warns kdunleavy Tue, 10/04/2022 – 10:37 More: AstraZeneca's Evusheld loses potency against new omicron subvariant, FDA warns Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals